AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,364 | -16.4% | 9,752 | -4.4% | 0.00% | -100.0% |
| Q2 2023 | $288,876 | +7.1% | 10,200 | -13.1% | 0.00% | 0.0% |
| Q1 2023 | $269,607 | -12.2% | 11,738 | +8.2% | 0.00% | 0.0% |
| Q3 2022 | $307,000 | +44.1% | 10,847 | +11.6% | 0.00% | – |
| Q2 2022 | $213,000 | -15.8% | 9,716 | +55.4% | 0.00% | -100.0% |
| Q3 2021 | $253,000 | -80.3% | 6,252 | -73.7% | 0.00% | -66.7% |
| Q2 2021 | $1,282,000 | +17.4% | 23,808 | -4.3% | 0.00% | 0.0% |
| Q1 2021 | $1,092,000 | +4.6% | 24,875 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $1,044,000 | -2.4% | 25,040 | -19.9% | 0.00% | 0.0% |
| Q3 2020 | $1,070,000 | -56.4% | 31,251 | -31.9% | 0.00% | -62.5% |
| Q2 2020 | $2,454,000 | +764.1% | 45,912 | +424.8% | 0.01% | +700.0% |
| Q1 2020 | $284,000 | -26.2% | 8,748 | +1.6% | 0.00% | 0.0% |
| Q4 2019 | $385,000 | +43.1% | 8,609 | -7.3% | 0.00% | 0.0% |
| Q3 2019 | $269,000 | -34.7% | 9,284 | +5.7% | 0.00% | 0.0% |
| Q2 2019 | $412,000 | -29.6% | 8,785 | -0.5% | 0.00% | -50.0% |
| Q1 2019 | $585,000 | -30.1% | 8,833 | -22.9% | 0.00% | -33.3% |
| Q4 2018 | $837,000 | +1.5% | 11,455 | +6.7% | 0.00% | 0.0% |
| Q3 2018 | $825,000 | +7.6% | 10,731 | +17.9% | 0.00% | 0.0% |
| Q2 2018 | $767,000 | +265.2% | 9,099 | +255.6% | 0.00% | +200.0% |
| Q1 2018 | $210,000 | +28.0% | 2,559 | -10.8% | 0.00% | 0.0% |
| Q4 2017 | $164,000 | +3180.0% | 2,869 | +3315.5% | 0.00% | – |
| Q3 2017 | $5,000 | +400.0% | 84 | +265.2% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 23 | +53.3% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 15 | -48.3% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 29 | -37.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |